Rheumatology Advisor

http://RheumatologyAdvisor.com provides healthcare specialists with a valuable resource filled with practical information on rheumatology to aid in their clinical decision-making. Our goal is to support rheumatology professionals by offering detailed and relevant clinical and medication information that aligns with the latest care principles, enabling clinicians to enhance patient outcomes effectively.

Trade/B2B

English

Newsletter (Digital), Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#592124

United States

#190352

Health/Health

#3617

Traffic sources

Monthly visitors

Articles

Metformin Reduces Knee Pain in Knee Osteoarthritis With Overweight, Obesity

3 days ago | rheumatologyadvisor.com | Ron Goldberg

Metformin has a moderate although statistically significant effect on reducing knee pain among patients with knee osteoarthritis and overweight or obesity, according to study findings published in the Journal of the American Medical Association. Metformin, currently used as first-line therapy for type 2 diabetes, also reduces inflammation among people with and without diabetes.
Adverse Pregnancy Outcomes After CV Events Highest in Women With SLE, Lupus Nephritis

4 days ago | rheumatologyadvisor.com | natasha persaud

It is well known that systemic lupus erythematosus (SLE) increases the risks for both pregnancy complications and cardiovascular events. Now a new study finds that women with SLE who experience cardiovascular events during pregnancy have higher risks of adverse maternal and infant outcomes, particularly when they have lupus nephritis or antiphospholipid antibodies (APS).
Long-Term CVD Risk Post COVID-19 Discharge Unaffected by Social Deprivation

1 week ago | rheumatologyadvisor.com | Ron Goldberg

Long-term cardiovascular risk after COVID-19 hospitalization discharge is unaffected based on county-level social deprivation, according to study findings published in the Journal of the American Heart Association. Investigators determined the incidence of death and post-discharge cardiovascular complications among survivors of COVID-19 hospitalization in the context of social vulnerability, patient-level and county-level, with post-discharge outcomes.
Men in US Experiencing Intimate Partner Violence Face Barriers to Care

1 week ago | rheumatologyadvisor.com | Ron Goldberg

In the United States, men experiencing intimate partner violence (IPV) have a gap in care access, especially men from minority backgrounds, according to systematic review study results presented at the American Psychiatric Association Annual Meeting, held virtually from May 17 to 21, 2025 in Los Angeles, California. Researchers assessed healthcare-setting disparities among men in the US experiencing IPV, and sought to identify barriers to care.
Additional Adverse Events Identified With Apremilast Use

1 week ago | rheumatologyadvisor.com | Jessica Nye

Additional relevant safety signals associated with apremilast use have been identified, according to the results of a study published in Archives of Dermatological Research. Apremilast is a small molecule phosphodiesterase-4 inhibitor that is approved by the United States (US) Food and Drug Administration (FDA) for the management of psoriatic arthritis and plaque psoriasis.
Recurrent Lupus Nephritis After Kidney Transplantation Characterized

1 week ago | rheumatologyadvisor.com | natasha persaud

Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent, investigators report. Among 112 first-time kidney transplant recipients with lupus nephritis history, 40 (35.7%) experienced lupus nephritis recurrence in the graft, Maria Lourdes Gonzalez Suarez, MD, PhD, of Mayo Clinic in Rochester, Minnesota, and colleagues reported in Kidney International Reports.
Clinical Knowledge About axSpA Is Limited Among Nonrheumatology Physicians

1 week ago | rheumatologyadvisor.com | Hibah Khaja

Nonrheumatology physicians (NRPs) in the United States demonstrate limited awareness and inconsistent clinical practices related to axial spondyloarthritis (axSpA), potentially contributing to delayed diagnoses and suboptimal patient outcomes, according to survey results published in The Journal of Rheumatology.
Lupus Nephritis Remission Duration Identified to Prevent Chronic Kidney Disease

2 weeks ago | rheumatologyadvisor.com | natasha persaud

In patients with active lupus nephritis, at least 3 years of sustained clinical remission is necessary to prevent kidney damage and onset of stage 3 or higher chronic kidney disease (CKD), a new study finds. Sustained clinical remission was defined as an estimated glomerular filtration rate (eGFR) of more than 60 mL/min/1.73 m2, proteinuria of less than 0.5 g/24h, and a clinical systemic lupus erythematosus (SLE) disease activity index of 0 for at least 1 year.
Testosterone Levels Linked to Sex-Specific OA Risks and Joint Pain

2 weeks ago | rheumatologyadvisor.com | Hibah Khaja

Higher levels of circulating testosterone may influence the risk and progression of osteoarthritis (OA) and chronic joint pain in sex-specific ways, according to study results published in Osteoarthritis and Cartilage. Researchers explored the association between total and free testosterone levels and various outcomes related to radiographic knee and hand OA, as well as chronic pain in the same joints, among a cohort of over 8600 participants from the population-based Rotterdam Study.
Pharmacists, Dermatologists Pick Top OTC Products for 2025-2026

2 weeks ago | rheumatologyadvisor.com | Steve Duffy

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025-2026. The third annual Best OTC Medicine & Health Products list includes 12 new OTC product categories, bringing the total number of categories to 133. The results were reached via a survey, conducted in partnership with The Harris Poll, and included responses from 357 pharmacists and 134 dermatologists practicing in the US.